BackIbere Pharmaceuticals Overview

Ibere Pharmaceuticals Current Cash

Ibere Pharmaceuticals's current cash is $4.5K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4453.00
↓ 99.35% YoYΔ $-675962.00 vs prior year quarter

Peer average

Loading

Ibere Pharmaceuticals Current Cash History

Loading

Ibere Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Ibere Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ibere Pharmaceuticals (IBER) FAQ

Ibere Pharmaceuticals posts a current cash of $4.5K as of September 2022. That compares with $680K in the prior-year period — down 99.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ibere Pharmaceuticals's current cash was $680K. The latest reading is $4.5K — a 99.3% year-over-year decrease (period ending September 2022). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Ibere Pharmaceuticals's financial statement story. At $4.5K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IBER's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Ibere Pharmaceuticals's other metric pages and overview cover the third.